UTHR logo

United Therapeutics (UTHR) Return On Equity

Annual ROE

18.27%
+1.66%+9.99%

December 31, 2023

Summary

Performance

1-Year Change

+9.99%

3-Year Change

+9.6%

5-Year Change

-23.59%

15-Year Change

-12.92%

UTHR ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.15%
UTHR annual return on equity is higher than 82.15% of companies in Healthcare sector

High & Low

All-time High

45.48%
UTHR annual return on equity is currently -59.83% below its historical high of 45.48%

3-Year Low

12.94%
UTHR annual return on equity is currently +41.19% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
UTHR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
UTHR next annual earnings announcement is scheduled for Feb 21, 2025

OtherUTHRprofitabilitymetrics:

Annual Revenue

$2.33 B
UTHR annual revenue is $2.33 billion

Annual Net Income

$984.80 M
UTHR annual net profit is $984.80 million

Annual EPS

$19.81
UTHR annual earnings per share is $19.81

Annual ROA

14.91%
UTHR annual return on assets is 14.91%

Quarterly ROE

19.26%
+0.26%+1.37%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+9.62%

3-Year Change

+9.62%

5-Year Change

-2.58%

UTHR Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.96%
UTHR quarterly return on equity is higher than 82.96% of companies in Healthcare sector

High & Low

All-time High

65.86%
UTHR quarterly return on equity is currently -70.76% below its historical high of 65.86%

3-Year Low

13.02%
UTHR quarterly return on equity is currently +47.93% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
UTHR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
UTHR next earnings announcement is scheduled for Feb 21, 2025

OtherUTHRprofitabilitymetrics:

Quarterly Revenue

$748.90 M
UTHR quarterly revenue is $748.90 million

Quarterly Net Income

$309.10 M
UTHR quarterly net profit is $309.10 million

Quarterly EPS

$6.39
UTHR quarterly earnings per share is $6.39

Quarterly ROA

16.09%
UTHR quarterly return on assets is 16.09%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

18.27%
UTHR annual return on equity is 18.27%

Annual Net Income

$984.80 M
UTHR annual net profit is $984.80 million

Annual Shareholders Equity

$5.98 B
UTHR annual stockholders equity is $5.98 billion

UTHR ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.0%+9.6%
3 y3 years+9.6%+9.6%
5 y5 years-23.6%-2.6%

UTHR ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+41.2%at high+47.9%
5 y5-yearat high+588.5%-2.6%+586.4%
alltimeall time-59.8%+119.2%-70.8%+124.5%

United Therapeutics ROE History

DateAnnualQuarterly
Sep 2024
-
19.26%(+1.4%)
Jun 2024
-
19.00%(-0.3%)
Mar 2024
-
19.05%(+4.6%)
Dec 2023
18.27%(+10.0%)
18.22%(+3.7%)
Sep 2023
-
17.57%(-2.4%)
Jun 2023
-
18.00%(+13.6%)
Mar 2023
-
15.85%(-4.9%)
Dec 2022
16.61%(+28.4%)
16.67%(-1.8%)
Sep 2022
-
16.97%(+7.2%)
Jun 2022
-
15.83%(-12.3%)
Mar 2022
-
18.04%(+38.6%)
Dec 2021
12.94%(-22.4%)
13.02%(-0.9%)
Sep 2021
-
13.14%(-5.9%)
Jun 2021
-
13.97%(+11.4%)
Mar 2021
-
12.54%(-24.5%)
Dec 2020
16.67%(-545.7%)
16.61%(+5.1%)
Sep 2020
-
15.81%(+3.7%)
Jun 2020
-
15.24%(-22.9%)
Mar 2020
-
19.77%(-599.2%)
Dec 2019
-3.74%(-115.6%)
-3.96%(+13.5%)
Sep 2019
-
-3.49%(-22.8%)
Jun 2019
-
-4.52%(-22.6%)
Mar 2019
-
-5.84%(-125.0%)
Dec 2018
23.91%(+14.0%)
23.35%(+2.3%)
Sep 2018
-
22.82%(-29.7%)
Jun 2018
-
32.46%(+40.5%)
Mar 2018
-
23.10%(+9.9%)
Dec 2017
20.98%(-49.1%)
21.01%(-20.2%)
Sep 2017
-
26.32%(+25.4%)
Jun 2017
-
20.99%(-40.4%)
Mar 2017
-
35.21%(-12.7%)
Dec 2016
41.23%(-9.3%)
40.32%(-3.5%)
Sep 2016
-
41.80%(-36.5%)
Jun 2016
-
65.86%(+1.6%)
Mar 2016
-
64.85%(+29.6%)
Dec 2015
45.48%(+71.8%)
50.04%(-7.5%)
Sep 2015
-
54.10%(+265.8%)
Jun 2015
-
14.79%(-1.9%)
Mar 2015
-
15.08%(-43.6%)
Dec 2014
26.47%(+81.9%)
26.75%(+76.7%)
Sep 2014
-
15.14%(-31.2%)
Jun 2014
-
22.01%(+11.9%)
Mar 2014
-
19.67%(+37.2%)
Dec 2013
14.55%(-50.9%)
14.34%(-41.8%)
Sep 2013
-
24.66%(-9.9%)
Jun 2013
-
27.38%(-1.0%)
Mar 2013
-
27.66%(-6.4%)
Dec 2012
29.64%(+25.4%)
29.56%(+14.9%)
Sep 2012
-
25.72%(-3.5%)
Jun 2012
-
26.64%(-2.2%)
Mar 2012
-
27.25%(+21.4%)
Dec 2011
23.64%
22.44%(+15.4%)
DateAnnualQuarterly
Sep 2011
-
19.45%(+23.6%)
Jun 2011
-
15.74%(+26.6%)
Mar 2011
-
12.43%(-8.7%)
Dec 2010
13.78%(+328.0%)
13.62%(+6.7%)
Sep 2010
-
12.77%(+33.4%)
Jun 2010
-
9.57%(+143.5%)
Mar 2010
-
3.93%(+22.4%)
Dec 2009
3.22%(-127.8%)
3.21%(-130.3%)
Sep 2009
-
-10.60%(-10.9%)
Jun 2009
-
-11.90%(+23.1%)
Mar 2009
-
-9.67%(-16.0%)
Dec 2008
-11.59%(-246.0%)
-11.51%(-196.7%)
Sep 2008
-
11.90%(-22.5%)
Jun 2008
-
15.36%(+5.9%)
Mar 2008
-
14.50%(+53.6%)
Dec 2007
7.94%(-74.3%)
9.44%(-73.5%)
Sep 2007
-
35.57%(+19.0%)
Jun 2007
-
29.90%(+6.5%)
Mar 2007
-
28.07%(+1.7%)
Dec 2006
30.84%(+10.7%)
27.61%(+58.4%)
Sep 2006
-
17.43%(-16.9%)
Jun 2006
-
20.97%(-14.3%)
Mar 2006
-
24.47%(-15.3%)
Dec 2005
27.86%(+224.0%)
28.89%(+40.0%)
Sep 2005
-
20.64%(+20.3%)
Jun 2005
-
17.16%(+25.2%)
Mar 2005
-
13.71%(+55.3%)
Dec 2004
8.60%(-246.5%)
8.83%(+182.1%)
Sep 2004
-
3.13%(-331.9%)
Jun 2004
-
-1.35%(-74.2%)
Mar 2004
-
-5.23%(-11.2%)
Dec 2003
-5.87%(-54.3%)
-5.89%(+7.5%)
Sep 2003
-
-5.48%(-52.8%)
Jun 2003
-
-11.62%(-1.4%)
Mar 2003
-
-11.78%(-8.5%)
Dec 2002
-12.85%(-25.7%)
-12.87%(-14.0%)
Sep 2002
-
-14.97%(+13.7%)
Jun 2002
-
-13.17%(-19.3%)
Mar 2002
-
-16.31%(-6.1%)
Dec 2001
-17.30%(-67.0%)
-17.37%(-37.0%)
Sep 2001
-
-27.57%(-3.6%)
Jun 2001
-
-28.59%(-30.2%)
Mar 2001
-
-40.98%(-16.6%)
Dec 2000
-52.44%(-45.0%)
-49.13%(+11.1%)
Sep 2000
-
-44.21%(-30.2%)
Jun 2000
-
-63.37%(+34.7%)
Mar 2000
-
-47.06%(-34.4%)
Dec 1999
-95.31%(+24.3%)
-71.73%(+28.9%)
Sep 1999
-
-55.63%(+12.2%)
Jun 1999
-
-49.59%(-37.0%)
Mar 1999
-
-78.71%
Dec 1998
-76.65%
-

FAQ

  • What is United Therapeutics annual return on equity?
  • What is the all time high annual ROE for United Therapeutics?
  • What is United Therapeutics annual ROE year-on-year change?
  • What is United Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for United Therapeutics?
  • What is United Therapeutics quarterly ROE year-on-year change?

What is United Therapeutics annual return on equity?

The current annual ROE of UTHR is 18.27%

What is the all time high annual ROE for United Therapeutics?

United Therapeutics all-time high annual return on equity is 45.48%

What is United Therapeutics annual ROE year-on-year change?

Over the past year, UTHR annual return on equity has changed by +1.66% (+9.99%)

What is United Therapeutics quarterly return on equity?

The current quarterly ROE of UTHR is 19.26%

What is the all time high quarterly ROE for United Therapeutics?

United Therapeutics all-time high quarterly return on equity is 65.86%

What is United Therapeutics quarterly ROE year-on-year change?

Over the past year, UTHR quarterly return on equity has changed by +1.69% (+9.62%)